Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide for Mycosis Fungoides and Sezary Syndrome
NCT00004106Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- May 1998
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in mycosis fungoides (MF) and Sézary syndrome (SS), sponsored by Northwestern University. Primary endpoint: Response Rate. Started May 1998; status: terminated.
02
Drugs
temozolomide
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT00004106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004106.